CD4+/CD25+ Cells in Systemic Inflammation in COPD

Scandinavian Journal of Immunology

Volumn 73, Issue 1, 2011, Pages 59-65

  Domagala Kulawik J ^a   Hoser, G ^b   DaBrowska, M ^a   Safianowska, A ^a   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD; BODY MASS; CD4+ CD25+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ANTIGENS, CD; AUTOIMMUNITY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY;

EID: 78650041389     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02474.x     Document Type: Article

References (38)

1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
2. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 2007;4:522-5.
3. Wouters EF, Groenewegen KH, Dentener MA et al. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007;4:626-34.
4. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:5s-13s.
5. Domagala-Kulawik J, Hoser G, Dabrowska M et al. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med 2007;101:1338-43.
6. Gadgil A, Duncan SR. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:531-41.
7. Hodge S, Hodge G, Holmes M, Reynolds PN. Apoptosis in COPD. Curr Respir Med Rev 2005;1:33-41.
8. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007;4:512-21.
9. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008;118:394-402.
10. Lee SH, Goswami S, Grudo A et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-9.
11. Feghali-Bostwick CA, Gadgil AS, Otterbein LE et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:156-63.
12. Leidinger P, Keller A, Heisel S et al. Novel autoantigens immunogenic in COPD Patients. Respir Res 2009;12:10-20.
13. Orentas RJ, Kohler ME, Johnson BD. Suppression of anti-cancer immunity by regulatory T cells: back to the future. Semin Cancer Biol 2006;16:137-49.
14. Bryl E, Daca A, Jozwik A et al. Human CD4(Low) CD25(High) regulatory T cells indiscriminately kill autologous activated T cells. Immunology 2009;128 (1 Suppl):e287-95.
15. Baecher-Allan C, Viglietta V, Hafler D. Human CD4+ CD25+ regulatory T cells. Seminars in Immunol 2004;16:89-97.
16. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002;3:611-18.
17. Smyth LJ, Starkey C, Vestbo J et al. CD4-regulatory cells in COPD patients. Chest 2007;132:156-63.
18. Barcelo B, Pons J, Ferrer JM et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+ CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008;31:555-62.
19. Takemura Y, Ouchi N, Shibata R et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 2007;117:375-86.
20. Summer R, Little FF, Ouchi N et al. Alveolar macrophage activation and an emphysema-like phenotype in Adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2008;294:L1035-42.
21. Tomoda K, Yoshikawa M, Itoh T et al. Elevated circulating plasma Adiponectin in underweight patients with COPD. Chest 2007;132:135-40.
22. Lefrancois L. Dual personality of memory T cells. Trends Immunol 2002;23:226-8.
23. Hodge S, Hodge G, Ahern J et al. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007;37:748-55.
24. Hodge G, Nairn J, Holmes M et al. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007;150:22-9.
25. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002;121 (5 Suppl):160S-5S.
26. Becker C, Kubach J, Wijdenes J et al. CD4-mediated functional activation of human CD4+ CD25+ regulatory T cells. Eur J Immunol 2007;37:1217-23.
27. Wei CM, Lee JH, Wang LC et al. Frequency and phenotypic analysis of CD4+ CD25+ regulatory T cells in children with juvenile idiopathic arthritis. J Microbiol Immunol Infect 2008;41:78-87.
28. Zielinski J, Bednarek M, Gorecka D et al. Increasing COPD awareness. Eur Respir J 2006;27:833-52.
29. Domagala-Kulawik J, Maskey-Warzecowska M. T-regulatory cells in COPD or tumour environment. Eur Respir J 2009;34:284-6.
30. D'Ambrosio D. Regulatory T cells: how do they find their space in the immunological arena? Semin Cancer Biol 2006;16:91-7.
31. Tang AL, Teijaro JR, Njau MN et al. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J Immunol 2008;181:1806-13.
32. Friedline RH, Brown DS, Nguyen H et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009;206 (2):421-34.
33. Zhu G, Agusti A, Gulsvik A et al. CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J 2009;34:598-604.
34. Miller M, Cho JY, Pham A et al. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009;182:684-91.
35. Kirdar S, Serter M, Ceylan E et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest 2009;69:219-24.
36. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001;17:946-53.
37. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-54.
38. Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 2003;123:1054-9.